Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics

Kidney International

Volumn 79, Issue 2, 2011, Pages 218-227

  Pun, Patrick H ^a   Lehrich, Ruediger W ^a   Honeycutt, Emily F ^a   Herzog, Charles A ^b   Middleton, John P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b United States Renal Data System   (United States)

Author keywords

cardiac; cardiovascular events; dialysis; end stage kidney disease; risk factors

Indexed keywords

CREATININE; POTASSIUM;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSATE; FEMALE; HEART ARREST; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 78650859922     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.315     Document Type: Article

References (47)

1. USRDS Annual Data Report. Digestive and Kidney Diseases. National Institutes of Health, National Institute of Diabetes: Bethesda, 2005.
2. Herzog CA. Can we prevent sudden cardiac death in dialysis patients? Clin J Am Soc Nephrol 2007; 2: 410-412.
3. Pun P, Lehrich RW, Smith SR et al. Predictors of survival following cardiac arrest in outpatient hemodialysis clinics. Clin J Am Soc Nephrol 2007; 2: 491-500.
4. Pun PH, Smarz TR, Honeycutt EF et al. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int 2009; 76: 652-658.
5. Deo R, Lin F, Vittinghoff E et al. Kidney dysfunction and sudden cardiac death among women with coronary heart disease. Hypertension 2008; 51: 1578 .
6. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999; 55: 1553-1559.
7. Bleyer AJ, Hartman J, Brannon PC et al. Characteristics of sudden death in hemodialysis patients. Kidney Int 2006; 69: 2268-2273.
8. Karnik JA, Young BS, Lew NL et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001; 60: 350-357.
9. Parekh RS, Plantinga LC, Kao WH et al. The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int 2008; 74: 1335-1342.
10. Herzog CA, Mangrum JM, Passman R. Sudden cardiac death and dialysis patients. Semin Dial 2008; 21: 300-307.
11. USRDS Annual Data Report. Digestive and Kidney Diseases. National Institutes of Health, National Institute of Diabetes: Bethesda, 2006.
12. Lehrich R, Pun PH, Tanenbaum ND et al. Automated external defibrillators and survival from cardiac arrest in the outpatient hemodialysis clinic. J Am Soc Nephrol 2007; 18: 312-320.
13. Kovesdy CP, Regidor DL, Mehrotra R et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2007; 2: 999-1007.
14. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001; 345: 1473-1482.
15. Ohtake T, Kobayashi S, Moriya H et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol 2005; 16: 1141-1148.
16. Herzog CA. Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. Kidney Int 2003; (Suppl): S197-S200.
17. Foley RN. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 2003; 16: 111-117.
18. Paoletti E, Specchia C, Di Maio G et al. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 2004; 19: 1829-1834.
19. Schietinger BJ, Brammer GM, Wang H et al. Patterns of late gadolinium enhancement in chronic hemodialysis patients. JACC Cardiovasc Imaging 2008; 1: 450-456.
20. Amann K, Ritz E, Wiest G et al. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 1994; 4: 1814-1819.
21. Rodriguez-Ayala E, Avila-Diaz M, Foyo-Niembro E et al. Effect of parathyroidectomy on cardiac fibrosis and apoptosis: possible role of aldosterone. Nephron Physiol 2006; 103: p112-p118.
22. Ganesh SK, Stack AG, Levin NW et al. Association of elevated serum PO(4), Ca PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138.
23. Rump LC, Amann K, Orth S et al. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol Dial Transplant 2000; 15: 1735-1738.
24. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482.
25. Coca SG, Perazella MA, Buller GK. The cardiovascular implications of hypokalemia. Am J Kidney Dis 2005; 45: 233-247.
26. Santoro A, Mancini E, London G et al. Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal. Nephrol Dial Transplant 2008; 23: 1415-1421.
27. Selby NM, McIntyre CW. The acute cardiac effects of dialysis. Semin Dial 2007; 20: 220-228.
28. Burton JO, Jefferies HJ, Selby NM et al. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 2009; 4: 914-920.
29. Movilli E, Gaggia P, Zubani R et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis A 5-year prospective observational multicentre study. Nephrol Dial Transplant 2007; 22: 3547-3552.
30. Okada K, Abe M, Hagi C et al. Prolonged protective effect of short daily hemodialysis against dialysis-induced hypotension. Kidney Blood Press Res 2005; 28: 68-76.
31. Srinivasan B, Alfred KC, Brett L et al. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr 2007; 17: 372.
32. Dwyer JT, Larive B, Leung J et al. Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study? Kidney Int 2005; 68: 1766-1776.
33. Cice G, Ferrara L, D'Andrea A et al. Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebocontrolled trial. J Am Coll Cardiol 2003; 41: 1438-1444.
34. Nishimura M, Tokoro T, Nishida M et al. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial. Am J Kidney Dis 2009; 54: 307-317.
35. Herzog CA, Li S, Weinhandl ED et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 2005; 68: 818-825.
36. Sakhuja R, Keebler M, Lai TS et al. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol 2009; 103: 735-741.
37. Echt DS, Liebson PR, Mitchell LB et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781-788.
38. Knoll GA, Sahgal A, Nair RC et al. Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients. Am J Med 2002; 112: 110-114.
39. Teng M, Wolf M, Ofsthun MN et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005; 16: 1115-1125.
40. Milliner DS, Zinsmeister AR, Lieberman E et al. Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 1990; 38: 931-936.
41. Szczech LA, Barnhart HX, Inrig JK et al. Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int 2008; 74: 791-798.
42. Bradbury BD, Danese MD, Gleeson M et al. Effect of Epoetin alfa dose changes on hemoglobin and mortality in hemodialysis patients with hemoglobin levels persistently below 11 g/dl. Clin J Am Soc Nephrol 2009; 4: 630-637.
43. Lauer MS, Blackstone EH, Young JB et al. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 1999; 34: 618-620.
44. Rocco MV, Yan G, Gassman J et al. Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis Health Care Financing Administration. Am J Kidney Dis 2002; 39: 146-153.
45. Davis TR, Young BA, Eisenberg MS et al. Outcome of cardiac arrests attended by emergency medical services staff at community outpatient dialysis centers. Kidney Int 2008; 73: 933-939.
46. Schlesselman JJ, Stolley PD. Case-Control Studies: Design, Conduct, Analysis. Oxford University Press: New York, 1982.
47. Steyerberg EW, Harrell Jr FE, Borsboom GJ et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001; 54: 774-781.